His main research concerns Nanomedicine, Drug delivery, Targeted drug delivery, Pharmacology and Drug. His Nanomedicine study is concerned with the field of Nanotechnology as a whole. His research integrates issues of Tumor targeting, Nanoparticle, Computational biology and Biodistribution in his study of Drug delivery.
His Targeted drug delivery research incorporates themes from Pharmaceutical sciences, Biophysics, Micelle and Therapeutic index. His Pharmacology study integrates concerns from other disciplines, such as Cancer cell, Cancer research and In vitro. His Drug research focuses on Combination therapy and how it relates to Cancer and Tumor targeted.
Twan Lammers focuses on Drug delivery, Nanomedicine, Pharmacology, Targeted drug delivery and Cancer research. His research in Drug delivery intersects with topics in Biomedical engineering, Microbubbles and Biodistribution. His Nanomedicine study incorporates themes from Cancer, Combination therapy, Tumor targeting and Intensive care medicine.
His Pharmacology study combines topics in areas such as In vitro, Liposome and Doxorubicin. His Targeted drug delivery study also includes
The scientist’s investigation covers issues in Nanomedicine, Drug delivery, Cancer, Cancer research and Immune system. Twan Lammers incorporates Nanomedicine and In patient in his research. He interconnects Microbubbles, Chemical engineering, Drug and Internalization in the investigation of issues within Drug delivery.
His study on Drug is covered under Pharmacology. The concepts of his Cancer study are interwoven with issues in Nanocarriers, Oncology and Biodistribution. In his work, Chemotherapy and Advanced stage is strongly intertwined with Tumor microenvironment, which is a subfield of Cancer research.
His scientific interests lie mostly in Nanomedicine, Drug delivery, Treatment efficacy, Drug and Biomedical engineering. His Nanomedicine research integrates issues from Clinical study design, Risk analysis and Engineering ethics. His study in the field of Nanocarriers is also linked to topics like In patient.
His study in Treatment efficacy is interdisciplinary in nature, drawing from both Immune system, Dexamethasone, Coronavirus disease 2019, Corticosteroid and Pharmacology. His studies in Drug integrate themes in fields like Cancer immunotherapy, Tumor targeting and Intensive care medicine. His biological study spans a wide range of topics, including Magnetic particle imaging, Blood–brain barrier, Magnetic resonance imaging, Hyperthermia and Dynamic light scattering.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Twan Gerardus Gertudis Maria Lammers;F. Kiessling;W.E. Hennink;Gerrit Storm;Gerrit Storm.
Journal of Controlled Release (2012)
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective ☆
Jennifer I. Hare;Twan Lammers;Twan Lammers;Marianne B. Ashford;Sanyogitta Puri.
Advanced Drug Delivery Reviews (2017)
Tumour-targeted nanomedicines: principles and practice.
T.G.G.M. Lammers;W.E. Hennink;G. Storm.
British Journal of Cancer (2008)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek;Jan Niklas May;Benjamin Theek;Lia Appold.
Advanced Drug Delivery Reviews (2018)
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner
Chunfu Zhang;Manfred Jugold;Eva C. Woenne;Twan Lammers.
Cancer Research (2007)
Nanotheranostics and image-guided drug delivery: current concepts and future directions.
Twan Lammers;Fabian Kiessling;Wim E. Hennink;Gert Storm.
Molecular Pharmaceutics (2010)
Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation
Marina Talelli;Matthias Barz;Cristianne J.F. Rijcken;Fabian Kiessling.
Nano Today (2015)
Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics
F. Kiessling;S. Fokong;P. Koczera;W. Lederle.
The Journal of Nuclear Medicine (2012)
Noninvasive Imaging of Nanomedicines and Nanotheranostics : Principles, Progress, and Prospects
Sijumon Kunjachan;Josef Ehling;Gert Storm;Fabian Kiessling.
Chemical Reviews (2015)
Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines
Sijumon Kunjachan;Robert Pola;Felix Gremse;Benjamin Theek.
Nano Letters (2014)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: